Li Li

机构：Guangzhou University of Chinese Medicine, Kunming Third People's Hospital, Heilongjiang Center for Tuberculosis Control and Prevention, Yunnan Provincial Infectious Disease Hospital · ORCID：0000-0003-0945-2946

发表论文 47 篇 · 总被引 954 次 · h-index 12

代表论文

• Correlation between immune-related adverse events and the efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: systematic review and meta-analysis (2021 · Cancer Chemotherapy and Pharmacology · 被引 25)
• Evaluating the diagnostic and prognostic value of serum TuM2‐PK , NSE, and ProGRP in small cell lung cancer (2023 · Journal of Clinical Laboratory Analysis · 被引 21)
• Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis (2022 · World Journal of Surgical Oncology · 被引 20)
• Optical genome mapping for detection of chromosomal aberrations in prenatal diagnosis (2023 · Acta Obstetricia Et Gynecologica Scandinavica · 被引 17)
• Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer (2021 · International Journal of Radiation Oncology*Biology*Physics · 被引 14)
• Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion (2022 · BMC Pulmonary Medicine · 被引 8)